The Advisory Committee on Immunization Practices (ACIP) in the US voted eight to three to withdraw the long-standing recommendation for universal hepatitis B vaccination at birth for infants of mothers who test negative for the hepatitis B virus.[1][2] Instead, it recommends shared clinical decision-making between parents and physicians about vaccine administration, including the birth dose.[2][3] For infants who do not receive the vaccine at birth, he suggests the first administration no earlier than two months of age.[1][2] This decision affects children born to test-negative mothers, while the birth dose continues to be recommended for children of test-positive or untested mothers.[3][6] Parents and doctors should consider the risks of infection, such as contact with persons with hepatitis B in the household or from areas of high incidence.[2] For later vaccination, the committee recommends testing for hepatitis B surface antigen antibody levels to assess protection.[2] This recommendation has yet to be approved by the CDC director.[3][4] It means a return to the strategy from more than 30 years ago.[3][4]